Green product lines include Nature-Cide, Thermal-Aid, Home Spa and Malibu Brands embracing the rapidly growing sectors of the economy.
Canoga Park, CA -- (ReleaseWire) -- 01/17/2019 --Med-X Inc is seeking to expand its market positioning through B2B marketing of the Nature-Cide product line for continued sales across the economic juggernauts of commercial pest control, hospitality, janitorial, transportation and agriculture sectors with a sharp eye on the emerging cannabis industry. On the B2C side, the company is preparing several products for big box retail across all of lines including their growing Aromatherapy Home Spa brand, and its Malibu Brands pain management products.
Beyond that, Med-X is expanding their market presence for Thermal-Aid in pain management sectors including insurance coverage segments for physical therapy, and care providers while moving ahead in the retail sector through the massive retail OTC pharmacy sector.
Making inroads into multiple growing markets to both businesses and consumers is fueled fastest through funding. The cannabis market alone is expected to expand year-over-year with billions in revenue annually. That being said, the Nature-Cide division couldn't be positioned better, as California wineries and German breweries face a public relations crisis due to the fact that a wide range of California wines and German beers have tested positive for toxic levels of glyphosate (Reference: Dr. Joseph Mercola) which is motivating these global sources of adult beverages and cannabis cultivators to look for other means of protecting their cash crops.
It's becoming obvious that conventional thinking and traditional approaches to ever-changing market forces and facts presented makes a fresh approach necessary. Clearly, Med-X is positioned for growth in an array of industry sectors critical to consumers and companies alike with entirely new methodology that delivers results with none of the negative impact.
Case in point; When considering the opioid crisis that everyone understands but no one knows how to stop, Med-X already has multiple solutions starting with Thermal-Aid. Thermal-Aid treats pain, muscle tension and light sensitivity simultaneously for fast, dependable, welcome relief in minutes. The Thermal-Aid Headache System is clinically proven to relieve tension and migraine headaches. The second pain management solution is the Malibu Brands Pacific Pain Relief Cream. The botanical blend of the Malibu Brands cream product, gives patients almost immediate relief from all types of chronic pain ailments, including arthritis, joint pain, headaches and more. No pills. No side effects. Created by a Board-certified physicians in multiple fields of medicine.
This established leader in green technologies is seeking equity crowdfunding to move forward with their existing product lines, creating new products and acquiring other companies in line with their operating philosophy and business plan to deliver safe, effective products to enhance every aspect of life.
Investors of every kind are invited to inspect their offering here - http://bit.ly/2STHoC1
The official Med-X Inc. website - https://medx-rx.com/
About Med-X Inc.
Med-X is a leader in green technology manufacturing. We help consumers and communities find solid solutions dedicated to achieving and living a healthy lifestyle without the concern of personal and environmental impact. This benefits not only our customers, but also our shareholders and partners. Med-X is further developing and expanding its digital media platform, The Marijuana Times, and developing cannabis related products in a legal and eco-friendly fashion.
No Offer or Solicitation Securities
This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.
Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements
There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.